On 18Mar2024, the FDA announced a new webpage to "showcase how the agency uses one of its oversight tools, inspections, to help ensure drug safety and quality."
The announcement goes on to state "The page highlights FDA's oversight of drug quality by providing an overview of the agency's work to carefully monitor drug manufacturers' compliance with current good manufacturing practice (CGMP) requirements. The page includes information about FDA's regulatory tools, such as warning letters, and actions following a CGMP inspection."
The link to the new webpage: Drug Quality, Current Good Manufacturing Practice Inspections and Comp
| U.S. Food and Drug Administration |
remove preview |
|
| Drug Quality, Current Good Manufacturing Practice Inspections and Comp |
| Hospitals, health systems and patients rely on FDA to ensure the medications that are available are safe, effective and of high quality. For application products, typically prescription drugs, FDA's approval process is the first step. FDA's drug application approval includes assessing the manufactur |
| View this on U.S. Food and Drug Administration > |
|
|
#fda #GMP #Compliance
------------------------------
Mark Arnold Ph.D., FAAPS
Westampton, NJ
[email protected]Bioanalytical Solution Integration
LinkedIn:
https://www.linkedin.com/in/markearnoldphd/Website & Blog: Bioanalysis & Biomarkers <bioanalysisandbiomarkers.blogspot.com>
------------------------------
</bioanalysisandbiomarkers.blogspot.com>